About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)
NovaBay Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative products for the eye care and dermatology markets. The company leverages its proprietary technology platform to create and market treatments that address unmet medical needs, primarily targeting infections and conditions that affect skin and eye health. NovaBay's product pipeline includes a range of topical antimicrobial and anti-inflammatory solutions, aiming to provide effective and safe alternatives for patients and healthcare professionals. Through its commitment to research and development, NovaBay seeks to enhance the quality of care and improve patient outcomes in various therapeutic areas. Read More
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
